Search

everythinglearnresearchcommunity

for

Search:↓

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

675 nm laser therapy effectively improves hair growth and density in AGA patients.

Exosomes show promise for future tissue regeneration.

Trichobiolight effectively treats hair loss with 82.5% success.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

People with male pattern baldness are more likely to have metabolic syndrome.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

UBM helps hair regrowth in men and women with hair loss.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Treat hair loss with medicine, continue indefinitely.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Invasive treatments can improve hair growth, but effectiveness varies and more research is needed.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

Skin symptoms often reveal hormonal imbalances in PCOS.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Microscopic hair analysis is important in forensics but has limitations; new technologies are improving its accuracy.

The new near-infrared LED device improves skin and hair with no side effects.